Skip to main content
. 2022 Dec 6;41(12):2166–2180. doi: 10.1200/JCO.22.00332

FIG 3.

FIG 3.

OS subgroup analyses in the all randomly assigned population. aStratified HR, 0.95. bPer interactive response technology. cStratified HR, 0.82. dStratified HR, 0.78. CPS, combined positive score; ECOG PS, Eastern Cooperative Oncology Group performance status; EXTREME, cetuximab plus cisplatin/carboplatin plus fluorouracil ≤ six cycles, then cetuximab maintenance; HR, hazard ratio; OPC, oropharyngeal cancer; OS, overall survival; PD-L1, programmed death-ligand 1.